SML3391

Glatiramer acetate

≥95% (HPLC)

• Synonym(e): Cop 1 (polyamide), Cop-1, Copaxone, Copolymer 1, GA, Polymer with L-alanine, L-lysine, L-tyrosine, and L-glutamic acid acetate
• Lineare Formel: (C₉H₁₁NO₃)_a·(C₆H₁₄N₂O₂)_b ·(C₅H₉NO₄)_c ·(C₃H₇NO₂)_d ·x(CH₃CO₂H)
• UNSPSC-Code: 12352200
• NACRES: NA.21

Eigenschaften

• Qualitätsniveau: 100
• Assay: ≥95% (HPLC)
• Form: (Powder or Lyophilized powder or film)
• Lagerbedingungen: desiccated
• Farbe: white to beige
• Lagertemp.: -10 to -25°C
• SMILES String: OC([C@@H](N)C)=O.OC(CC[C@H](N)C(O)=O)=O.NCCCC[C@H](N)C(O)=O.OC([C@@H](N)CC1=CC=C(C=C1)O)=O

Beschreibung

Biochem./physiol. Wirkung

Glatiramer acetate, a myelin basic protein mimetic, is an immunomodulator used for treatment of Multiple Sclerosis. Glatiramer acetate is a mixture of synthetic peptides randomly composed of glutamic acid, lysine, alanine, and tyrosine. It reduces relapse rate and disease progression in Multiple Sclerosis. Its mechanism of action is not fully understood. Glatiramer acetate generates anti-inflammatory Th2 cells, which produce neurotrophic factors.

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable